Subsidiary of Zhejiang Yatai Pharmaceutical (002370.SZ) plans to subscribe to investment fund units worth 30 million yuan.

Zhejiang Yatai Pharmaceutical (002370.SZ) announced that its wholly-owned subsidiary, Zhejiang Yatai Li Zhong Holdings Co., Ltd., as a limited partner, intends to subscribe to 30 million yuan of Jiaxing Yuyan Equity Investment Partnership Enterprise's (limited partnership) fund raising quota with its own funds, accounting for 30% of its total committed capital. The fund will invest in high-quality unlisted company equity, private transactions of listed company securities, and other equity assets in the healthcare industry such as pharmaceutical research and development, production, services, and innovative technologies. This investment aims to leverage the industry resources, fund operations, and professional investment management experience of professional investment institutions to further expand the investment layout in the pharmaceutical and healthcare field, deepen cooperation with high-quality enterprises in the industry, reserve high-quality research and development projects, and further promote the long-term development of the company's industry.